Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
The Journal of Infectious Diseases
|
March 28, 2003
Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control
Susan A Sufka, Guido Ferrari, Victoria E Gryszowka, et al.
The Journal of Experimental Medicine
|
December 22, 2004
Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes
Xavier Valencia, Jonathan M G Higgins, Hans P Kiener, et al.
The Journal of Allergy and Clinical Immunology
|
August 10, 2016
β-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis
Frank Kolbinger, Christian Loesche, Marie-Anne Valentin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 6, 2004
Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation
De Yang, Qian Chen, Helene F Rosenberg, et al.
JCI Insight
|
March 15, 2017
Retinoic-acid-orphan-receptor-C inhibition suppresses Th17 cells and induces thymic aberrations
Christine Guntermann, Alessandro Piaia, Marie-Laure Hamel, et al.
The Journal of Allergy and Clinical Immunology
|
April 4, 2006
Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology
Jordan S Orange, Elham M Hossny, Catherine R Weiler, et al.
Science Translational Medicine
|
October 8, 2010
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis
Wolfgang Hueber, Dhavalkumar D Patel, Thaddeus Dryja, et al.
Blood
|
October 4, 2017
Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib
V Koneti Rao, Sharon Webster, Virgil A S H Dalm, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 13, 2015
Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation
Frédéric Bornancin, Florian Renner, Ratiba Touil, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
The Journal of Infectious Diseases
|
March 28, 2003
Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control
Susan A Sufka, Guido Ferrari, Victoria E Gryszowka, et al.
The Journal of Experimental Medicine
|
December 22, 2004
Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes
Xavier Valencia, Jonathan M G Higgins, Hans P Kiener, et al.
The Journal of Allergy and Clinical Immunology
|
August 10, 2016
β-Defensin 2 is a responsive biomarker of IL-17A-driven skin pathology in patients with psoriasis
Frank Kolbinger, Christian Loesche, Marie-Anne Valentin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 6, 2004
Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation
De Yang, Qian Chen, Helene F Rosenberg, et al.
JCI Insight
|
March 15, 2017
Retinoic-acid-orphan-receptor-C inhibition suppresses Th17 cells and induces thymic aberrations
Christine Guntermann, Alessandro Piaia, Marie-Laure Hamel, et al.
The Journal of Allergy and Clinical Immunology
|
April 4, 2006
Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology
Jordan S Orange, Elham M Hossny, Catherine R Weiler, et al.
Science Translational Medicine
|
October 8, 2010
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis
Wolfgang Hueber, Dhavalkumar D Patel, Thaddeus Dryja, et al.
Blood
|
October 4, 2017
Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib
V Koneti Rao, Sharon Webster, Virgil A S H Dalm, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 13, 2015
Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation
Frédéric Bornancin, Florian Renner, Ratiba Touil, et al.
Page
of 5